Daniel B. Swartzlander

ORCID: 0009-0002-7255-3846
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Esophageal Cancer Research and Treatment
  • Neuroendocrine Tumor Research Advances
  • Single-cell and spatial transcriptomics
  • Radiomics and Machine Learning in Medical Imaging
  • Pancreatitis Pathology and Treatment
  • Infectious Diseases and Mycology
  • Genetic factors in colorectal cancer
  • Alzheimer's disease research and treatments
  • Helicobacter pylori-related gastroenterology studies
  • Lung Cancer Research Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lung Cancer Treatments and Mutations
  • Steroid Chemistry and Biochemistry
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Microbial Metabolic Engineering and Bioproduction
  • Fungal and yeast genetics research
  • Cardiovascular Effects of Exercise
  • Nuclear Receptors and Signaling
  • RNA modifications and cancer
  • Autophagy in Disease and Therapy
  • Caveolin-1 and cellular processes
  • Peptidase Inhibition and Analysis

Invitae (United States)
2021-2025

The University of Texas MD Anderson Cancer Center
2019-2023

Cancer Research Center
2019-2020

Scripps MD Anderson Cancer Center
2020

Baylor College of Medicine
2014-2018

Emory University
2007-2016

Nationwide Children's Hospital
2005

The progression of tau pathology in Alzheimer’s disease follows a stereotyped pattern, and recent evidence suggests role synaptic connections this process. Astrocytes are well positioned at the neuronal synapse to capture degrade extracellular as it transits hence could potentially have ability inhibit spreading delay progression. Our study shows increased expression activity Transcription Factor EB (TFEB), master regulator lysosomal biogenesis, response both human brains with dementia...

10.1084/jem.20172158 article EN cc-by-nc-sa The Journal of Experimental Medicine 2018-08-14

Our understanding of the origins new metabolic functions is based upon anecdotal genetic and biochemical evidence. Some auxotrophies can be suppressed by overexpressing substrate-ambiguous enzymes (i.e., those that catalyze same chemical transformation on different substrates). Other exhibit weak but detectable catalytic promiscuity in vitro they transformations similar Cells adapt to novel environments through evolution these secondary activities, neither their natures nor frequencies...

10.1093/molbev/msm204 article EN Molecular Biology and Evolution 2007-06-29

Heterogeneity is a hallmark of cancer. The advent single-cell technologies has helped uncover heterogeneity in high-throughput manner different cancers across varied contexts. Here we apply sequencing to reveal inherent assumptively monoclonal pancreatic cancer (PDAC) cell lines and patient-derived organoids (PDOs). Our findings high degree both genomic transcriptomic polyclonality monolayer PDAC lines, custodial variation induced by growing apparently identical laboratories, shifts...

10.1038/s41467-022-31376-3 article EN cc-by Nature Communications 2022-06-25

BACKGROUND: Truncating variants (TTNtvs) in the titin ( TTN ) gene have been associated with cardiomyopathies or arrhythmias (C/A) and autosomal recessive neuromuscular diseases (NM). However, clinical significance of TTNtvs across entire coding sequence has not comprehensively assessed. The purpose this study was to examine burden C/A NM cases compared controls genome aggregation database. METHODS: This a retrospective probands who underwent multigene testing (49 740 panel, 24 514 panel)...

10.1161/circgen.124.004982 article EN Circulation Genomic and Precision Medicine 2025-02-19

Abstract Purpose: Most patients with pancreatic ductal adenocarcinoma (PDAC) present surgically unresectable cancer. As a result, endoscopic ultrasound–guided fine-needle aspiration (EUS-FNA) is the most common biospecimen source available for diagnosis in treatment-naïve patients. Unfortunately, these limited samples are often not considered adequate genomic analysis, precluding opportunity enrollment on precision medicine trials. Experimental Design: Applying an epithelial cell adhesion...

10.1158/1078-0432.ccr-20-2667 article EN Clinical Cancer Research 2020-11-13

Intraductal papillary mucinous neoplasms (IPMN) are cystic precursor lesions to pancreatic ductal adenocarcinoma (PDAC). IPMNs undergo multistep progression from low-grade (LG) high-grade (HG) dysplasia, culminating in invasive neoplasia. While patterns of IPMN have been analyzed using multiregion sequencing for somatic mutations, there is no integrated assessment molecular events, including copy-number alterations (CNA) and transcriptional changes that accompany progression. We performed...

10.1158/2767-9764.crc-22-0419 article EN cc-by Cancer Research Communications 2023-09-18

Seven human disorders of postsqualene cholesterol biosynthesis have been described. One these, congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD) syndrome, results from mutations in the X-linked gene NADH sterol dehydrogenase-like (NSDHL) encoding a dehydrogenase. A series mutant alleles murine Nsdhl are carried by bare patches (Bpa) mice, Bpa(1H) representing null allele. Heterozygous females display skin skeletal abnormalities distribution reflecting random X...

10.1194/jlr.m400462-jlr200 article EN cc-by Journal of Lipid Research 2005-04-02

Abstract Intratumoral heterogeneity (ITH) is a hallmark of cancer. The advent single-cell technologies has helped uncover ITH in high-throughput manner different cancers across varied contexts. Here we apply sequencing to reveal striking assumptively oligoclonal pancreatic ductal adenocarcinoma (PDAC) cell lines. Our findings high degree both genomic and transcriptomic established globally utilized PDAC lines, custodial variation induced by growing apparently identical lines laboratories,...

10.1101/2021.04.13.439717 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2021-04-13

Abstract Intraductal papillary mucinous neoplasms (IPMNs) are cystic precursor lesions to pancreatic ductal adenocarcinoma (PDAC). IPMNs undergo multistep progression from low grade (LG) high (HG) dysplasia, culminating in invasive neoplasia. While patterns of IPMN have been analyzed using multi-region sequencing for somatic mutations, there is no integrated assessment molecular events, including copy number alterations (CNAs) and transcriptomics changes, that accompany progression. We...

10.1101/2022.10.14.512148 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-10-18

<div>AbstractPurpose:<p>Most patients with pancreatic ductal adenocarcinoma (PDAC) present surgically unresectable cancer. As a result, endoscopic ultrasound–guided fine-needle aspiration (EUS-FNA) is the most common biospecimen source available for diagnosis in treatment-naïve patients. Unfortunately, these limited samples are often not considered adequate genomic analysis, precluding opportunity enrollment on precision medicine trials.</p>Experimental...

10.1158/1078-0432.c.6530151 preprint EN 2023-03-31

<div>AbstractPurpose:<p>Most patients with pancreatic ductal adenocarcinoma (PDAC) present surgically unresectable cancer. As a result, endoscopic ultrasound–guided fine-needle aspiration (EUS-FNA) is the most common biospecimen source available for diagnosis in treatment-naïve patients. Unfortunately, these limited samples are often not considered adequate genomic analysis, precluding opportunity enrollment on precision medicine trials.</p>Experimental...

10.1158/1078-0432.c.6530151.v1 preprint EN 2023-03-31
Coming Soon ...